Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
---|
12/24/2003 | WO2003091232A3 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them |
12/24/2003 | WO2003084940B1 Thiazolidine-4-carbonitriles and analogues and their use as dipeptidyl-peptidas inhibitors |
12/24/2003 | WO2003064384A3 Environment friendly reagents and process for trifluoromethylsulfinylation of organic compounds |
12/24/2003 | WO2003039454A3 Beta-secretase inhibitors and methods of use |
12/24/2003 | WO2002028829A3 Peptide deformylase inhibitors |
12/24/2003 | CN1463263A Method to inhibit ethylene responses in plants |
12/24/2003 | CN1131870C 新的吡咯磺酰胺化合物 The new pyrrole sulfonamide compound |
12/24/2003 | CA2489095A1 Aspartyl protease inhibitors |
12/24/2003 | CA2486215A1 Mitotic kinesin inhibitors |
12/23/2003 | US6667376 Control agents for living-type free radical polymerization and methods of polymerizing |
12/23/2003 | US6667342 Benzenesulfonamide-derivatives and their use as medicaments |
12/23/2003 | US6667318 LFA-1 antagonist compounds |
12/23/2003 | US6667301 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
12/18/2003 | WO2003104249A1 Novel linker for nucleotides |
12/18/2003 | WO2003104220A1 Asymetric synthesis of amino-pyrrolidinones |
12/18/2003 | WO2003103772A1 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the teatment of eye diseases such as glaucoma |
12/18/2003 | WO2003103604A2 Gamma lactams as prostaglandin agonists and use thereof |
12/18/2003 | WO2003103567A2 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors |
12/18/2003 | WO2003074500A3 N-aminoacetyl-pyrrolidine-2-carbonitriles and their use as ddp-iv inhibitors |
12/18/2003 | WO2002083030A3 Bifunctional energy-reversible acyl-compositions |
12/18/2003 | US20030232986 Inhibitors of caspases |
12/18/2003 | US20030232841 Amides such as 5-(2-(4-methylpiperazin-1-yl)-phenyl)-furan-2-carboxylic acid 4-chlorobenzylamide, used as antidepressants and for prophylaxis of headaches |
12/18/2003 | US20030232836 Secondary amides such as 2-(4-(2- methoxyphenyl)-1-piperazinyl )-N-(3-methylphenyl)acetamide, used for prophylaxis of impotency |
12/18/2003 | US20030232826 Amidino and guanidino peptidyl compounds |
12/18/2003 | US20030232811 Anthranilic acid derivative |
12/18/2003 | US20030232808 Sulfonyl derivatives |
12/18/2003 | US20030232806 Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them |
12/18/2003 | US20030232800 Non-symmetric tripyrranes in the synthesis of novel macrocycles |
12/18/2003 | US20030229949 Hair dyes; fast coloration of keratin fibers |
12/18/2003 | CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof |
12/17/2003 | EP1371645A1 Process for the preparation of the 2'-(R)-Glycopyrronium Enantiomers and their use in medicaments |
12/17/2003 | EP1370525A1 Biguanide derivatives |
12/17/2003 | EP1370522A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
12/17/2003 | EP1370520A1 Aryl and biaryl compounds having mch modulatory activity |
12/17/2003 | EP1370514A1 1,3-diamino-4-(aminomethyl)-benzene derivatives and colorants containing said compounds |
12/17/2003 | EP1370258A2 Peptide deformylase inhibitors |
12/17/2003 | EP1257534B1 Novel process for preparing 4-substituted-1h-pyrrole-3-carboxylic acid ester |
12/17/2003 | EP1082302B1 A vla-4 inhibitor: omepupa-v |
12/17/2003 | CN1462268A Substituted cinnamic acid guanidides, method for the production thereof, their use as medicament, and medicine containing these compounds |
12/17/2003 | CN1462267A Method for producing ketocarbodylic acid derivatives |
12/17/2003 | CN1131222C Benzamide derivs and their use as APOB-100 secretion inhibitors |
12/17/2003 | CN1131209C Alkyl dihalogenated phenyl-substituted ketoenols useful as. pesticides and herbicides |
12/17/2003 | CN1131202C Calcium receptor-active compounds |
12/16/2003 | US6664262 N-methoxymethyl-5,5-diphenylbarbituric acid |
12/16/2003 | CA2248407C Thermally stable aminosulfur trifluorides |
12/16/2003 | CA2122633C 2-heterocyclicethylamine derivatives and their use as pharmaceuticals |
12/11/2003 | WO2003101959A1 Pyrrole compounds for the treatment of prostaglandin mediated diseases |
12/11/2003 | WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
12/11/2003 | WO2003101956A1 Pharmaceutical combination |
12/11/2003 | WO2003101449A2 Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof |
12/11/2003 | WO2003101448A1 The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases |
12/11/2003 | WO2003101391A2 Therapeutic methods |
12/11/2003 | WO2003080566A3 Hif hydroxylase inhibitors |
12/11/2003 | WO2003057666A3 Inhibitors of dipeptidyl peptidase iv |
12/11/2003 | WO2003040288A3 Isotopically coded affinity markers 3 |
12/11/2003 | WO2002100802A3 Fluorous triphase and other multiphase systems |
12/11/2003 | WO2002085925A3 Melanocortin receptor ligands |
12/11/2003 | WO2002083067A3 Prodrugs via acylation with cinnamate |
12/11/2003 | WO2002062778A3 Anti-thrombotic compounds, production and use thereof as medicaments |
12/11/2003 | WO2002060383A3 Cancer therapy |
12/11/2003 | US20030229229 Anticancer agents; kinase inhibitors; antiallergens; autoimmune disease; rheumatic diseases; skin disorders |
12/11/2003 | US20030229228 Plant safening agents; fungicides |
12/11/2003 | US20030229226 Cathepsin cysteine protease inhibitors |
12/11/2003 | US20030229133 Amidine inhibitors of serine proteases |
12/11/2003 | US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction |
12/11/2003 | US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents |
12/11/2003 | US20030229092 Antidiabetic agents; antiinflammatory agents; analgesics; antiallergens |
12/11/2003 | US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents |
12/11/2003 | US20030229070 Pyrrolothiazine and pyrrolothiazepine compounds having serotonin-2 receptor antagonist and alpha-1-blocking action |
12/11/2003 | US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections |
12/11/2003 | US20030228978 Catalysts containing per-ortho aryl substituted aryl or heteroaryl substituted nitrogen donors |
12/11/2003 | CA2487636A1 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
12/11/2003 | CA2486110A1 Pharmaceutical combination |
12/10/2003 | EP1369692A2 Sensor surface |
12/10/2003 | EP1369416A1 Stable crystals of pyrrole compound |
12/10/2003 | EP1369415A1 Substituted pyrrolyl compounds for the treatment of inflammation |
12/10/2003 | EP1369414A1 Enantiomerically pure Arylcycloalkyl hydroxycarboxylic esters, processes for their preparation and their use as modulators of muscarinic receptors |
12/10/2003 | EP1368389A1 Complexed compounds and use thereof for the polymerisation of olefins |
12/10/2003 | EP1368316A1 Oxoammonium salts and the use thereof |
12/10/2003 | EP1368315A1 Method for preparing amlodipine |
12/10/2003 | EP1368311A1 Delta1 -pyrrolines used in pest control |
12/10/2003 | EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
12/10/2003 | CN1461298A Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
12/10/2003 | CN1130403C In situ block copolymer formation during polymerization of vinyl axomatic monomer |
12/10/2003 | CN1130365C Alpha-1 adrenergic compounds, drug composition containing same and their use |
12/09/2003 | US6660742 Alkylation therapy; anticancer agent |
12/09/2003 | US6660741 Coupling an O-protected methoxypyrrolidine or derivatives with N-protected amino acid 2,5-dioxo-pyrrolidinyl ester to form intermediate, deportecting with trifluoroacetic acid to form pyrrolidine-1-carbonyl-2-methylamine or derivatives |
12/04/2003 | WO2003099819A2 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics |
12/04/2003 | WO2003099785A1 Process for the preparation of amorphous atorvastatin calcium |
12/04/2003 | WO2003099784A1 Method for preparation of pharmaceutical-grade disulfide of dithiocarbamates |
12/04/2003 | WO2003099776A1 Calcium receptor modulating arylalkylamines |
12/04/2003 | WO2003099769A1 Anilino liver x-receptor modulators |
12/04/2003 | WO2003099274A1 Hepatitis c virus inhibitors |
12/04/2003 | WO2003099266A2 Acetamides and benzamides that are useful in treating sexual dysfunction |
12/04/2003 | WO2003022217A3 Treatment of excessive radiation (e.g. sunburn) exposure |
12/04/2003 | US20030225271 Compounds useful as reversible inhibitors of cysteine proteases |
12/04/2003 | US20030225270 E.g., 4-acetylamino-N-(1-((4-cyano-1-methylpiperidin-4-yl-carbamoyl)-2 -(cyclohexylethyl)benzamide; Alzheimer's, auto-immune and Crohn's diseases; atherosclerosis; antiarthritic agents; osteoporosis; atherosclerosis |
12/04/2003 | US20030225228 A catalyst for the polymerization of olefins, contains a titanium zirconium or hafnium complex of a dianionic bidentate ligand, (at least one of donor atoms of the ligand is a nitrogen atom substituted by a pyrrolyl group) |
12/04/2003 | US20030225149 Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids |
12/04/2003 | US20030225102 Dipeptidyl peptidase inhibitors; heterocyclic amide and semicarbazide derivatives, e.g., (2-Cyano-1-(piperazine-2-yl)-carbonyl pyrrolidine bis-trifluoroacetate |